Seeking Alpha

Merck (MRK) said yesterday it won another lawsuit brought by a patient who said the company's...

Merck (MRK) said yesterday it won another lawsuit brought by a patient who said the company's osteoporosis drug Fosamax caused jaw problems. Merck, which faces more than 2,300 lawsuits connected to Fosamax, said it has won five of the six Fosamax-related lawsuits that have gone to trial.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector